Challenges in applying chemometrics to LC-MS-based global metabolite profile data

Bioanalysis

Volumn 1, Issue 4, 2009, Pages 805-819

  Want, Elizabeth ^a  

^a Department of Biomolecular Medicine Division of Surgery Oncology Reproductive Biology and Anaesthetics Faculty of Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS; FEMALE; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; METHODOLOGY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; REVIEW; STATISTICAL ANALYSIS;

ANALYTIC SAMPLE PREPARATION METHODS; CHROMATOGRAPHY, LIQUID; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; LIMIT OF DETECTION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS;

EID: 77953585789     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.64     Document Type: Review

References (123)

1. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 29(11), 1181-1189 (1999).
2. Nicholson JK, Connelly J, Lindon JC et al. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1(2), 153-161 (2002).
3. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol. 48(1-2), 155-171 (2002).
4. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature 23, 455 (7216), 1054-1056 (2008).
5. Rezzi S, Martin FP, Kochhar S. Defning personal nutrition and metabolic health through metabonomics. Ernst Schering Found. Symp. Proc. (4), 251-264 (2007).
6. Holmes E, Loo RL, Stamler J et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453(7193), 396-400 (2008).
7. Gieger C, Geistlinger L, Altmaier E et al. Genetics meets metabolomics: a genome-wide association study of metabolite profles in human serum. PLoS Genet. 4(11), e1000282 (2008).
8. Xu EY, Schaefer WH, Xu Q. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. Curr. Opin. Drug Discov. Devel. 12(1), 40-52 (2009).
9. Wishart DS. Applications of metabolomics in drug discovery and development. Drugs R D 9(5), 307-322 (2008).
10. Clarke CJ, Haselden JN. Metabolic profling as a tool for understanding mechanisms of toxicity. Toxicol Pathol. 36(1), 140-147 (2008).
11. Chen C, Krausz KW, Idle JR et al. Identifcation of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. J. Biol. Chem. 283(8), 4543-4559 (2008).
12. Bollard ME, Keun HC, Beckonert O et al. Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol. Appl. Pharmacol. 204(2), 135-151 (2005).
13. Lindon JC, Holmes E, Nicholson JK. Metabonomics in pharmaceutical R&D. FEBS J. 274(5), 1140-1151 (2007).
14. Coen M, Holmes E, Lindon JC et al. NMR-based metabolic profling and metabonomic approaches to problems in molecular toxicology. Chem. Res. Toxicol. 21(1), 9-27 (2008).
15. Hinkelbein J, Feldmann RE Jr, Peterka A et al. Alterations in cerebral metabolomics and proteomic expression during sepsis. Curr. Neurovasc. Res. (4), 280-288 (2007).
16. Bertini I, Calabro A, De Carli V et al. The metabonomic signature of celiac disease. J. Proteome Res. 8(1), 170-177 (2009).
17. Kaddurah-Daouk R, Krishnan KR. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 34(1), 173-186 (2009).
18. Rozen S, Cudkowicz ME, Bogdanov M et al. Metabolomic analysis and signatures in motor neuron disease. Metabolomics 1(2), 101-108 (2005).
19. Odunsi K. Cancer diagnostics using 1H-NMR-based metabonomics. Ernst Schering Found. Symp. Proc. (4), 205-226 (2007).
20. Gowda GA, Zhang S, Gu H et al. Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn. 8(5), 617-633 (2008).
21. Viant MR. Recent developments in environmental metabolomics. Mol Biosyst. 4(10), 980-986 (2008).
22. Viant MR, Bearden DW, Bundy JG et al. International NMR-based environmental metabolomics intercomparison exercise. Environ. Sci. Technol. 43(1), 219-225 (2009).
23. Simpson MJ, McKelvie JR. Environmental metabolomics: new insights into earthworm ecotoxicity and contaminant bioavailability in soil. Anal. Bioanal. Chem. 394(1), 137-149 (2009).
24. Roessner U, Luedemann A, Brust D et al. Metabolic profling allows comprehensive phenotyping of genetically or environmentally modifed plant systems. Plant Cell 13(1), 11-29 (2001).
25. Hoekenga OA. Using metabolomics to estimate unintended effects in transgenic crop plants: problems, promises, and opportunities. J. Biomol. Tech. 19(3), 159-166 (2008).
26. Allwood JW, Ellis DI, Goodacre R. Metabolomic technologies and their application to the study of plants and plant-host interactions. Physiol. Plant. 132(2), 117-135 (2008).
27. Dixon RA, Gang DR, Charlton AJ et al. Applications of metabolomics in agriculture. J. Agric. Food Chem. 54(24), 8984-8994 (2006).
28. Garcia DE, Baidoo EE, Benke PI et al Separation and mass spectrometry in microbial Metabolomics. Curr. Opin. Microbiol. 11(3), 233-239 (2008).
29. Larsen TO, Smedsgaard J, Nielsen KF et al. Phenotypic taxonomy and metabolite profling in microbial drug discovery Nat. Prod. Rep. 22(6), 672-695 (2005).
30. Mashego MR, Rumbold K, De Mey M et al. Microbial metabolomics: past, present and future methodologies. Biotechnol. Lett. 29(1), 1-16 (2007).
31. Fiehn O, Kopka J, Dörmann P et al. Metabolite profling for plant functional genomics. Nat. Biotechnol. 18(11), 1157-1161(2000).
32. Kell DB. Metabolomics and systems biology: making sense of the soup. Curr. Opin. Microbiol. 7(3), 296-307 (2004).
33. Fernie AR, Trethewey RN, Krotzky AJ, Willmitzer L. Metabolite profling: from diagnostics to systems biology. Nat. Rev. Mol. Cell. Biol. 5(9), 763-769 (2004).
34. Villas-Bôas SG, Rasmussen S, Lane GA. Metabolomics or metabolite profles? Trends Biotechnol. 23(8), 385-386 (2005).
35. Goodacre R, Vaidyanathan S, Dunn WB et al. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 22(5), 245-252 (2004).
36. Dunn WB, Bailey NJ, Johnson HE. Measuring the metabolome: current analytical technologies. Analyst 130(5), 606-625 (2005).
37. Lindon JC, Holmes E, Nicholson JK. Metabonomics in pharmaceutical R&D. FEBS J. 274(5), 1140-51 (2007).
38. Pan Z, Raftery D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics Anal. Bioanal. Chem. 387(2), 525-527 (2007).
39. Lenz EM, Wilson ID. Analytical strategies in metabonomics. J. Proteome Res. 6(2), 443-458 (2007).
40. Coen M, Holmes E, Lindon JC et al. NMR-based metabolic profling and metabonomic approaches to problems in molecular toxicology. Chem. Res. Toxicol. 21(1), 9-27 (2008).
41. Lenz EM, Bright J, Wilson ID et al. Metabonomics, dietary infuences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J. Pharm. Biomed. Anal. 36(4), 841-849 (2004).
42. Katajamaa M, Oresic M. Data processing for mass spectrometry-based metabolomics. J. Chromatogr. A. 1158(1-2), 318-328 (2007).
43. Sumner LW, Urbanczyk-Wochniak E, Broeckling CD. Metabolomics data analysis, visualization, and integration. Methods Mol. Biol. 406, 409-436 (2007).
44. Robinson MD, De Souza DP, Keen WW et al. A dynamic programming approach for the alignment of signal peaks in multiple gas chromatography-mass spectrometry experiments. BMC Bioinformatics 8, 419 (2007).
45. Adourian A, Jennings E, Balasubramanian R et al. Correlation network analysis for data integration and biomarker selection. Mol. Biosyst. 4(3), 249-259 (2008).
46. Xu Y, Gong F, Dixon SJ et al. Application of dissimilarity indices, principal coordinates analysis, and rank tests to peak tables in metabolomics of the gas chromatography/mass spectrometry of human sweat. Anal. Chem. 79(15), 5633-5641 (2007).
47. Plumb RS, Stumpf CL, Granger JH et al. Use of liquid chromatography/time- of-fight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fuids. Rapid Commun. Mass Spectrom. 17 (23), 2632-2638. (2003).
48. Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 26(1), 51-78 (2007).
49. Idborg H, Edlund PO, Jacobsson SP. Multivariate approaches for effcient detection of potential metabolites from liquid chromatography/mass spectrometry data. Rapid Commun. Mass Spectrom. 18 (9), 944-954 (2004).
50. Wilson ID, Plumb R, Granger J et al. HPLC-MS-based methods for the study of metabonomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 817(1), 67-76 (2005).
51. Want EJ, O'Maille G, Smith CA et al. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profling with mass spectrometry. Anal. Chem. 78(3), 743-52 (2006).
52. Werner E, Heilier JF, Ducruix C et al. Mass spectrometry for the identifcation of the discriminating signals from metabolomics: current status and future trends. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871(2), 143-63 (2008).
53. Want EJ, Nordström A, Morita H et al. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J. Proteome Res. 6(2), 459-468 (2007).
54. Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 26(1), 51-78 (2007).
55. Dunn WB. Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Phys. Biol. 5(1), 11001 (2008).
56. Nováková L, Solichová D, Solich P. Advantages of ultra performance liquid chromatography over high-performance liquid chromatography: comparison of different analytical approaches during analysis of diclofenac gel. J. Sep. Sci. 29(16), 2433-2443 (2006).
57. Plumb R, Castro-Perez J, Granger J et al. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-fight mass spectrometry. Rapid Commun. Mass Spectrom. 18, 2331-2337 (2004).
58. Zelena E, Dunn WB, Broadhurst D et al. Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal. Chem. 81(4), 1357-1364 (2009).
59. Gika HG, Macpherson E, Theodoridis GA et al. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profling of human urine samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871(2), 299-305 (2008).
60. Baker JM, Hawkins ND, Ward JL. A metabolomic study of substantial equivalence of feld-grown genetically modifed wheat. Plant Biotechnol. J. 4, 381-392 (2006).
61. van der Greef J, Davidov E, Verheij ER et al. Metabolic Profling: its Role in Biomarker Discovery and Gene Function Analysis. Harrigan GG, Goodacre R (Eds). Kluwer Academic Publishers, MA, USA (2003).
62. Broadhurst DI, Kell DB. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2(4), 171-196 (2006).
63. Katz JE, Dumlao DS, Clarke S et al. A new technique (COMSPARI) to facilitate the identifcation of minor compounds in complex mixtures by GC-MS and LC-MS: tools for the visualization of matched datasets. J. Am. Soc. Mass Spectrom. 15(4), 580-584 (2004).
64. Baran R, Kochi H, Saito N et al. MathDAMP: a package for differential analysis of metabolite profles. BMC Bioinformatics 13(7), 530 (2006).
65. Broeckling CD, Reddy IR, Duran AL et al. MET-IDEA: data extraction tool for mass spectrometry-based metabolomics Anal. Chem. 78(13), 4334-4341 (2006).
66. Duran AL, Yang J, Wang L et al. Metabolomics spectral formatting, alignment and conversion tools (MSFACTs). Bioinformatics 19(17), 2283-2293 (2003).
67. Katajamaa M, Oresic M. Processing methods for differential analysis of LC-MS profle data. BMC Bioinformatics 6, 179 (2005).
68. Katajamaa M, Miettinen J, Oresic M. MZmine: toolbox for processing and visualization of mass spectrometry based molecular profle data. Bioinformatics 22 (5), 634-636 (2006).
69. Kind T, Tolstikov V, Fiehn O et al. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem. 363(2), 185-195 (2007).
70. Sturm M, Bertsch A, Gröpl C et al. OpenMS-an open-source software framework for mass spectrometry. BMC Bioinformatics 26(9), 163 (2008).
71. Smith CA, Want EJ, O'Maille G et al. XCMS: processing mass spectrometry data for metabolite profling using nonlinear peak alignment, matching, and identifcation. Anal. Chem. 78 (3), 779-787 (2006).
72. Benton HP, Wong DM, Trauger SA et al. XCMS2: processing tandem mass spectrometry data for metabolite identifcation and structural characterization. Anal. Chem. 80(16), 6382-6389 (2008).
73. Tautenhahn R, Bottcher C, Neumann S. Highly sensitive feature detection for high resolution LC-MS. BMC Bioinformatics 9(1), 504 (2008).
74. Dunn WB, Broadhurst D, Brown M et al. Metabolic profling of serum using ultra performance liquid chromatography and the LTQ-Orbitrap mass spectrometry system. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871(2), 288-298 (2008).
75. Lange E, Tautenhahn R, Neumann S et al. Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements. BMC Bioinformatics 15(9), 375 (2008).
76. Stefansson M, Sjoberg PJR, Markides KE. Regulation of multimer formation in electrospray mass spectrometry. Anal. Chem. 68, 1792-1797 (1996).
77. +. Rapid Commun. Mass Spectrom. 11, 1083-1088 (1997).
78. Ding J, Anderegg RJ. Specifc and nonspecifc dimer formation in the electrospray ionization mass spectrometry of oligonucleotides. J. Am. Soc. Mass Spectrom. 6, 159-(1995).
79. Jiang H, Somogyi A, Timmermann BN et al. Instrument dependence of electrospray ionization and tandem mass spectrometric fragmentation of the gingerols. Rapid Commun. Mass Spectrom. 20, 3089-3100 (2006).
80. + in a mass spectrometer. J. Mass Spectrom. 31, 749 (1996).
81. James PF, Perugini MA, O'Hair RA. Sources of artefacts in the electrospray ionization mass spectra of saturated diacylglycerophosphocholines: from condensed phase hydrolysis reactions through to gas phase intercluster reactions. J. Am. Soc. Mass Spectrom. 17(3), 384-394 (2006).
82. Tautenhahn R, Bottcher C, Neumann S. Annotation of LC/ESI-MS mass signals. In: Bioinformatics Research and Development. Hochreiter S, Wagner R (Eds). Springer, Berlin, Germany, 371 (2007).
83. Nordström A, O'Maille G, Qin C et al. Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum. Anal. Chem. 78(10), 3289-3295 (2006).
84. Yu K, Little D, Plumb R et al. High-throughput quantifcation for a drug mixture in rat plasma- A comparison of ultra performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry Rapid Commun. Mass Spectrom. 20(4), 544-552 (2006).
85. Frenzel T, Miller A, Engel KH. A methodology for automated comparative analysis of metabolite profling data. Eur. Food Res. Technol. 216, 1438-2377 (2004).
86. Parab GS, Rao R, Lakshminarayanan S et al. Data-driven optimization of metabolomics methods using rat liver samples. Anal. Chem. 81(4), 1315-1323 (2009).
87. Bijlsma S, Bobeldijk I, Verheij ER et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal. Chem. 78(2), 567-574 (2006).
88. Lutz NW, Viola A, Malikova I et al. Infammatory multiple-sclerosis plaques generate characteristic metabolic profles in cerebrospinal fuid. PLoS ONE 2(7), e595 (2007).
89. Ruperez FJ, Garcia-Martinez D, Baena B. Dunaliella salina extract effect on diabetic rats: metabolic fngerprinting and target metabolite analysis. J. Pharm. Biomed. Anal. 49(3), 786-792 (2009).
90. Brereton RG. Consequences of sample size, variable selection, model validation and optimisation for predicting classifcation ability from analytical data. Trends Analyt. Chem. 25, 1103-1111 (2006).
91. Scholz M, Selbig J. Visualization and analysis of molecular data. Methods Mol. Biol. 358, 87-104 (2007).
92. Eriksson L, Antti H, Gottfries J et al. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal. Bioanal. Chem. 380(3), 419-429 (2004).
93. Trygg J, Holmes E, Lundstedt T Chemometrics in metabonomics. J. Proteome Res. 6(2), 469-479 (2007).
94. Vogt W, Nagel D. Cluster analysis in diagnosis. Clin. Chem. 38(2), 182-198 (1992).
95. Crockford DJ, Holmes E, Lindon JC et al. Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal. Chem. 78(2), 363-371 (2006).
96. van der Greef J, Smilde AK. Symbiosis of chemometrics and metabolomics: past, present, and future. J. Chemometrics 19, 376 (2005).
97. Yeung KY, Ruzzo WL. Principal component analysis for clustering gene expression data. Bioinformatics 17 (9), 763-774 (2001).
98. Jolliffe IT. Principal Component Analysis (2nd Edition). Springer, NY, USA (2002).
99. Wang Y, Tao Y, Lin Y et al. Integrated analysis of serum and liver metabonome in liver transplanted rats by gas chromatography coupled with mass spectrometry. Anal. Chim. Acta 633(1), 65-70 (2009).
100. Murdoch TB, Fu H, MacFarlane S et al. Urinary metabolic profles of infammatory bowel disease in interleukin-10 gene-defcient mice. Anal. Chem. 80(14), 5524-5531 (2008).
101. Scholz M, Gatzek S, Sterling A et al. Metabolite fngerprinting: detecting biological features by independent component analysis. Bioinformatics 20(15), 2447-2454 (2004).
102. Jonsson P, Johansson ES, Wuolikainen A et al. Predictive metabolite profling applying hierarchical multivariate curve resolution to GC-MS data- A potential tool for multi-parametric diagnosis. J. Proteome Res. 5(6), 1407-1414 (2006).
103. De Souza DP, Saunders EC, McConville MJ et al. Progressive peak clustering in GC-MS Metabolomic experiments applied to Leishmania parasites. Bioinformatics 22(11), 1391-1396 (2006).
104. Tikunov Y, Lommen A, de Vos CH et al. A novel approach for nontargeted data analysis for metabolomics. Large-scale profling of tomato fruit volatiles. Plant Physiol. 139(3), 1125-1137 (2005).
105. Burton L, Ivosev G, Tate S et al. Instrumental and experimental effects in LC-MS-based metabolomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871(2), 227-235 (2008).
106. Ivosev G, Burton L, Bonner R. Dimensionality reduction and visualization in principal component analysis. Anal. Chem. 80(13), 4933-4944 (2008).
107. Hyvärinen A, Oja E. Independent component analysis: algorithms and applications. Neural Netw. 13(4-5), 411-430 (2000).
108. Scholz M, Selbig J. Visualization and analysis of molecular data. Methods Mol. Biol. 358, 87-104 (2007).
109. Lutz U, Lutz RW, Lutz WK. Metabolic profling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classifcation and prediction of gender. Anal. Chem. 78(13), 4564-44571 (2006).
110. Barker M, Rayens W. Partial least squares for discrimination. J. Chemometrics 17(3), 166-173 (2003).
111. Martens H, Naes T. Multivariate Calibration. John Wiley & Sons Inc., NY, USA (1989).
112. Malinowski ER. Factor Analysis in Chemistry. Wiley-Interscience, NY, USA (1991).
113. Bylesjo M, Rantalainen M, Cloarec O et al. OPLS discriminant analysis: Combining the strengths of PLS-DA and SIMCA classifcation. J. Chemometrics 20(8-10), 341-351 (2006).
114. Trygg J. O2-PLS for qualitative and quantitative analysis in multivariate calibration. J. Chemometrics 16(6) 283-293 (2002).
115. Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemometrics 16(3), 119-128 (2002).
116. Brereton RG. Consequences of sample size, variable selection, and model validation and optimisation, for predicting classifcation ability from analytical data Trends Anal. Chem. 25, 1103-1111 (2006).
117. Anderssen E, Dyrstad K, Westad F et al. Reducing over-optimism in variable selection by cross-model validation. Chemometrics Intelligent Lab. Sys. 84(1-2), 69-74 (2006).
118. Eriksson L, Johansson E, Kettaneh-Wold N et al. Multi-and Megavariate Data Analysis: Principles and Applications. Umetrics Academy, Umea, Sweden (2001).
119. Smith CA, O'Maille G, Want EJ et al. METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27(6), 747-751 (2005).
120. Weckwerth W, Morgenthal K. Metabolomics: from pattern recognition to biological interpretation. Drug Discov. Today 10(22), 1551-1558 (2005).
121. Saghatelian A, Trauger SA, Want EJ et al. Assignment of endogenous substrates to enzymes by global metabolite profling. Biochemistry 43(45), 14332-14339 (2004).
122. Cho JY, Kang DW, Ma X et al. Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation. J. Lipid Res. 50(5), 924-937 (2009).
123. Böcker S, Rasche F. Towards de novo identifcation of metabolites by analyzing tandem mass spectra. Bioinformatics 24(16), i49-i55 (2008).